Literature DB >> 17881355

The mitotic regulator Survivin binds as a monomer to its functional interactor Borealin.

Eric Bourhis1, Sarah G Hymowitz, Andrea G Cochran.   

Abstract

Survivin is a member of the IAP (inhibitor of apoptosis) protein family, defined in part by the presence of a zinc-binding baculoviral inhibitory repeat (BIR) domain. Most BIR domains bind short sequences beginning with alanine, and in this manner, they recognize and block the action of key targets in apoptotic pathways. However, Survivin binds only very weakly to typical IAP ligands. Unique features of Survivin are the long C-terminal helix following the BIR domain and a short segment (linking the helix and BIR domains) that mediates Survivin homodimerization. Despite this detailed knowledge of the structure of Survivin itself, there is a current lack of understanding about how Survivin recognizes cellular binding partners, and consequently, many questions about Survivin function remain unanswered. We determined two co-crystal structures of Survivin and a minimal binding fragment from the chromosomal passenger protein Borealin, a well validated functional interactor. The interaction between Survivin and Borealin involves extensive packing between the long C-terminal helix of Survivin and a long Borealin helix. Surprisingly, an additional important interaction occurs between the Survivin homodimerization interface and a short segment of Borealin. This segment both structurally mimics and displaces one Survivin monomer. The relevance of this unexpected interaction was tested by mutagenesis of two key Borealin residues. Mutant Borealin introduced into HeLa cells failed to localize properly during mitosis and also caused mislocalization of other chromosomal passenger proteins. This suggests that the mutant is dominant-negative and confirms the functional importance of the interaction surface identified in the crystal structures.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17881355     DOI: 10.1074/jbc.M706233200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Survivin inhibition by an interacting recombinant peptide, derived from the human ferritin heavy chain, impedes tumor cell growth.

Authors:  Astrid Weiss; Boris Brill; Corina Borghouts; Natalia Delis; Laura Mack; Bernd Groner
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-18       Impact factor: 4.553

Review 2.  Increasing the range of drug targets: interacting peptides provide leads for the development of oncoprotein inhibitors.

Authors:  Bernd Groner; Axel Weber; Laura Mack
Journal:  Bioengineered       Date:  2012-07-24       Impact factor: 3.269

3.  Survivin and pancreatic cancer.

Authors:  Bin-Bin Liu; Wei-Hong Wang
Journal:  World J Clin Oncol       Date:  2011-03-10

4.  Threonine 48 in the BIR domain of survivin is critical to its mitotic and anti-apoptotic activities and can be phosphorylated by CK2 in vitro.

Authors:  Rachel M A Barrett; Rita Colnaghi; Sally P Wheatley
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

Review 5.  Survivin and IAP proteins in cell-death mechanisms.

Authors:  Dario C Altieri
Journal:  Biochem J       Date:  2010-09-01       Impact factor: 3.857

Review 6.  Survivin - The inconvenient IAP.

Authors:  Dario C Altieri
Journal:  Semin Cell Dev Biol       Date:  2015-01-12       Impact factor: 7.727

7.  Hydrogen exchange-mass spectrometry measures stapled peptide conformational dynamics and predicts pharmacokinetic properties.

Authors:  Xiangguo Eric Shi; Thomas E Wales; Carl Elkin; Noriyuki Kawahata; John R Engen; D Allen Annis
Journal:  Anal Chem       Date:  2013-11-14       Impact factor: 6.986

8.  Liaisons between survivin and Plk1 during cell division and cell death.

Authors:  Rita Colnaghi; Sally P Wheatley
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

9.  A link between aurora kinase and Clp1/Cdc14 regulation uncovered by the identification of a fission yeast borealin-like protein.

Authors:  K Adam Bohnert; Jun-Song Chen; Dawn M Clifford; Craig W Vander Kooi; Kathleen L Gould
Journal:  Mol Biol Cell       Date:  2009-07-01       Impact factor: 4.138

10.  Rational design of the survivin/CDK4 complex by combining protein-protein docking and molecular dynamics simulations.

Authors:  Jana Selent; Agnieszka A Kaczor; Ramon Guixà-González; Pau Carrió; Manuel Pastor; Cristian Obiol-Pardo
Journal:  J Mol Model       Date:  2012-12-21       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.